ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
NCT01905514 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2019-04-22
Summary
Nonadherence to immunosuppression is a leading cause of late graft rejection, chronic rejection and graft failure and it is regarded as a preventable cause of graft loss after solid organ transplantation. The purpose of this study is to evaluate whether mobile application for drug medication can enhance the drug adherence rate.
Conditions
- Kidney Transplantation
Interventions
- DEVICE
-
internet mobile application
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jongwon Ha, MD, PhD · Seoul National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2017-12-01
- Completion
- 2019-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Using Smartphone Application After Liver Transplantation
NCT05854472 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
NCT02963103 ·Status: TERMINATED ·Phase: PHASE4
-
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients
NCT01198314 ·Status: UNKNOWN ·Phase: PHASE2
-
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
NCT00556933 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
NCT01154387 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Medication Adherence in Children Who Had a Liver Transplant
NCT01154075 ·Status: COMPLETED
-
Immune Tolerance After Pediatric Liver Transplantation
NCT05501301 ·Status: RECRUITING
-
A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant
NCT00200551 ·Status: COMPLETED ·Phase: PHASE4
-
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
NCT00135694 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates
NCT03507348 ·Status: TERMINATED ·Phase: NA
-
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
NCT02334488 ·Status: COMPLETED ·Phase: PHASE3
-
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
NCT01028092 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient
NCT01592253 ·Status: UNKNOWN ·Phase: NA
-
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
NCT00078559 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
NCT00275522 ·Status: COMPLETED ·Phase: PHASE4
-
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
NCT02426502 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
NCT02251691 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
NCT00261820 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients
NCT03515330 ·Status: WITHDRAWN ·Phase: NA
-
Protective Immunity Project 01
NCT00788021 ·Status: COMPLETED
-
Iguratimod in Kidney Transplant Recipients
NCT02839941 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients
NCT03427008 ·Status: WITHDRAWN ·Phase: NA
-
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.
NCT06147648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
NCT05613010 ·Status: RECRUITING ·Phase: NA
-
Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
NCT00514514 ·Status: COMPLETED ·Phase: PHASE3